SCHEMBL25327624

SCHEMBL25327624

CCOc1ccc(CN2CCN(CC(=O)OC(C)(C)C)CCN(C(CC(=O)OC)C(=O)OC)CCN(CC(=O)OC(C)(C)C)CC2)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.43
KDM4E B2RXH2 5/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
LMNA P02545 2/20 0.43
MAPK1 P28482 2/20 0.42
HTT P42858 2/20 0.42
MAPT P10636 1/20 0.42
ACHE P22303 1/20 0.42
PKM P14618 2/20 0.41
ALDH1A1 P00352 4/20 0.40
CACNA1B Q00975 1/20 0.40
APBA1 Q02410 1/20 0.40
SAE1 Q9UBE0 1/20 0.40
UBA2 Q9UBT2 1/20 0.40
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
TDP1 Q9NUW8 1/20 0.38
ACACB O00763 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29589448 0.91 FAAH (0.42) FAAHKDM4ESMN1; SMN2LMNAMAPK1
SCHEMBL26185648 0.85 SMN1; SMN2 (0.47) FAAHKDM4ESMN1; SMN2LMNAMAPK1
SCHEMBL29096933 0.83 ADORA3 (0.41) FAAHKDM4EMAPK1ALDH1A1MEN1
SCHEMBL29096934 0.83 ADORA3 (0.41) FAAHKDM4EMAPK1ALDH1A1MEN1
SCHEMBL27028931 0.83 ADORA3 (0.40) FAAHALDH1A1MEN1KMT2APOLB
SCHEMBL29926484 0.80 ADORA3 (0.42) FAAHKDM4ESMN1; SMN2LMNAALDH1A1
SCHEMBL27028901 0.80 ALDH1A1 (0.42) KDM4EALDH1A1MEN1KMT2ATDP1
SCHEMBL25915555 0.80 FAAH (0.42) FAAHKDM4ESMN1; SMN2LMNAMAPK1
SCHEMBL27028968 0.79 ACACB (0.40) FAAHKDM4ELMNAALDH1A1MEN1
SCHEMBL29928332 0.78 MEN1 (0.40) KDM4ELMNAMAPK1MAPTACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12589169-B2 Compound and MRI contrast agent containing same KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) 2026-03-31 US disclosed
EP-4219510-B1 NOVEL COMPOUND AND MRI CONTRAST AGENT COMPRISING THE SAME KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND (KR) 2026-01-07 EP disclosed
US-20230330272-A1 COMPOUND AND MRI CONTRAST AGENT CONTAINING SAME KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) 2023-10-19 US disclosed
EP-4219510-A1 NOVEL COMPOUND AND MRI CONTRAST AGENT CONTAINING SAME Kyungpook National University Industry-Academic Cooperation Foundation (KR) 2023-08-02 EP disclosed
WO-2022092602-A1 NOVEL COMPOUND AND MRI CONTRAST AGENT CONTAINING SAME 경북대학교 산학협력단 2022-05-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12589169-B2 Compound and MRI contrast agent containing same TMEM165, SLC10A1, HKDC1 FAAH 1701/4885KDM4E 785/4885SMN1; SMN2 1462/4885
US-20230330272-A1 COMPOUND AND MRI CONTRAST AGENT CONTAINING SAME SLC10A1, FABP1, SLC10A2 FAAH 706/4885KDM4E 1951/4885SMN1; SMN2 254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.